首頁 > 市場調查報告書 > 醫療設備

電子醫療設備

市場調查報告書

商品編碼

1336716

全球醫用電極市場 - 2023-2030

Global Medical Electrodes Market - 2023-2030

出版日期: 2023年08月22日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球醫療電極市場將於 2022 年達到 9 億美元，預計到 2030 年將達到 12 億美元，2023-2030 年預測期間年複合成長率為 4.1%。

醫用電極能夠對內部離子電流進行表面測量，從而對幾種神經、肌肉、眼科、心臟和其他疾病進行非侵入性診斷，這些疾病通常需要手術干涉來確認其存在。電極通常使用簡單、拋棄式（或易於消毒），並且在其所協助的活動中通常是獨特的。電極的主要功能是保持患者和用於測量或記錄活動的儀器之間的最佳電接觸。

此外，全球醫療電極市場受到多種因素的推動，例如心血管和神經系統疾病的增加、技術進步、微創手術的增加、醫療保健支出的增加以及對早期疾病檢測和管理的認知不斷提高。

市場動態

心血管疾病患病率上升

心血管疾病患病率的上升是推動醫療電極市場在預測期內成長的重要關鍵因素之一，因為與此類疾病相關的高死亡率風險增加了患者頻繁醫療診斷的比率。例如，根據美國疾病控制與預防中心更新的情況說明書，每 40 秒就有 805,000 人經歷一次心臟病發作，其中 605,000 人是首次心臟病發作，200,000 人是已經經歷過心臟病的人。大約五分之一的心臟病發作是無聲的，在患者不知情的情況下造成損害。

技術進步的崛起

醫用電極通常用於心電圖 (ECG) 監測系統來診斷心臟問題。心電圖是最廣泛使用的心血管疾病診斷方法，並且測試技術正在不斷改進以滿足當今的技術需求。與標準的心臟動態心電圖和事件記錄儀相比，這種革命性的技術設備更具成本效益且方便用戶使用。

此外，隨著電極的小型化和電極電纜的消除，設備現在可以安裝在患者的胸部，而無需纏結電線。在分析期間，醫療設備的此類技術發展極大地促進了市場成長。

例如，2022 年 10 月 5 日，卡內基梅隆大學的研究人員開發了 CMU 陣列——一種用於腦機介面平台的微電極陣列。該解決方案有望改變醫生治療各種神經疾病的方式。此類創新將促進醫療電極市場的採用。

嚴格的政府法規

嚴格的政府法規是預測期內阻礙市場成長的限制因素之一。嚴格的政府法規在醫療電極市場中至關重要，因為它們確保了產品的安全、品質和功效。這些法規有助於維持高標準、促進創新和保護患者福祉。遵守這些要求對於製造商來說至關重要，有助於確保醫用電極的整體可靠性。

此外，在一些新興或不已開發國家，缺乏對此類設備的相關技術突破和優勢的了解可能會阻礙該市場在預測期內的成長。

Market Overview

Global Medical Electrodes Market reached US$ 0.9 billion in 2022 and is expected to reach US$ 1.2 billion by 2030 growing with a CAGR of 4.1% during the forecast period 2023-2030.

Medical electrodes enable the surface measurement of internal ionic currents, resulting in a non-invasive diagnostic for several neurological, muscular, ophthalmic, cardiac, and other illnesses that would normally require surgical intervention to confirm their presence. The electrodes are often simple to use, disposable (or readily sterilizable), and often distinctive in the activities they assist with. The electrode's primary function is to maintain optimal electrical contact between the patient and the instrument used to measure or record activity.

Furthermore, the global medical electrodes market is driven by various factors like rising cardiovascular and neurological diseases, technological advancements, a rise in minimally invasive surgeries, increasing healthcare spending, and rising awareness about early disease detection and management.

Market Dynamics

Rise in the Prevalence of Cardiovascular Diseases

The rise in the prevalence of cardiovascular diseases is one of the significant key factors that helps the medical electrodes market to grow during the forecast period, owing to the high mortality risk associated with such disorders has increased the rate of frequent medical diagnosis of patients. For instance, according to the Centers for Disease Control and Prevention updated factsheet in the US, 805,000 people experience a heart attack every 40 seconds, with 605,000 being first-time cases and 200,000 being those who have already experienced one. About 1 in 5 heart attacks are silent, causing damage without the person being aware.

Rise in Technological Advancements

Medical electrodes are often used in electrocardiogram (ECG) monitoring systems to diagnose heart problems. ECG has been the most widely utilised type of diagnostics for cardiovascular diseases, and testing techniques are improving to match today's technological needs. The revolutionary technology-incorporated devices, as opposed to standard cardiac holter and event recorders, are far more cost-effective and user-friendly.

Furthermore, with the miniaturisation of electrodes and the elimination of electrode cables, devices may now be installed on the patient's chest without a tangle of wires. During the analysis period, such technical developments in medical devices considerably enhanced market growth.

For instance, on 5th October 2022, researchers at Carnegie Mellon University developed the CMU Array - a microelectrode array for brain-computer interface platforms. The solution is expected to transform the way doctors treat various neurological ailments. Such innovations will bolster the medical electrodes market adoption.

Stringent Government Regulations

Stringent government regulations are one of the restraints that hamper market growth during the forecast period. As stringent government regulations are critical in the medical electrodes market because they ensure product safety, quality, and efficacy. These regulations aid in the maintenance of high standards, the promotion of innovation, and the protection of patient well-being. Compliance with such requirements is critical for manufacturers and helps to ensure the overall reliability of medical electrodes.

Furthermore, a lack of knowledge about the associated technical breakthroughs and advantages of such devices in some emerging or underdeveloped countries may impede the growth of this market during the forecast period.

Segment Analysis

The global medical electrodes market is segmented based on product type, type, application, end-user and region.

The Diagnostic Medical Electrodes From the Product Segment Accounted for Approximately 41.7% of the Medical Electrodes Share

The diagnostic medical electrodes from the product segment with around 41.7% is expected to dominate during the forecast period owing to recent launches by key players, technological advancements will drive the segment growth. For instance, in November 2022, Brain Scientific a Florida-based medical device technology company, announced the immediate release of the improved and updated NeuroCap device and the signing of a distribution partnership with D&D Medical, Inc., to sell the company's neurology devices in Tennessee, Kentucky, Indiana, and West Virginia.

Brain Scientific developed the NeuroCap to streamline EEG prep, testing and diagnosis. NeuroCap has 22 pre-gelled electrodes making it a suitable option for most clinical EEG tests, including routine EEGs that are often used for stroke and epilepsy patients. The fixed electrode placement is in accordance with the international 10-20 system.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share in 2022

North America is estimated to hold about 38.4% of the total market share throughout the forecast period, due to its superior healthcare infrastructure, new launches, effective government policies, vast multinational company base, and a high level of awareness about testing and testing devices in healthcare. This region also witnesses a high prevalence of chronic inflammatory disorders, such as cardiovascular diseases, diabetes, inflammatory bowel disease (IBD), and cancer, compared to other chronic indications.

Increasing expenditure on healthcare and rising awareness among people, advancement of technologies for treatment, and increase in biopharmaceutical establishment across the region are also contributing to the growth of medical electrodes share of this region.

For instance, in May 2023 NeuroOne Medical Technologies Corporation, a medtech company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced the commercial launch of the Evo sEEG electrode product line in the United States.

Competitive Landscape

The major global players in the medical electrodes market include Medtronic, Koninklijke Philips N.V., Ambu, Natus Medical Incorporated, 3M, CONMED Corporation, Rhythmlink International, LLC, Leonhard Lang GmbH, Nihon Kohden Corporation, Compumedics and among others

COVID-19 Impact Analysis

Segmentation

By Product Type

Diagnostic Medical Electrodes

Electrocardiography

Electroencephalogram

Electromyography

Therapeutic Medical Electrodes

Defibrillator

Transcutaneous Electrical Nerve Stimulation electrodes

Electrosurgical Electrodes

Neuromuscular and Muscular Electrical Stimulation (NMES)

Pacemaker electrodes

By Type

Wet Electrodes
Dry Electrodes
Needle Electrodes

By Application

Cardiac
Neurophysiology
Sleep Disorders
Intraoperative Monitoring
Others

By End User

Hospitals
Diagnostic Centers
Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

Middle East and Africa

Key Developments

In December 2022 NeuroOne Medical Technologies Corporation fulfilled a commercial order for sEEG electrodes and shipped them to Zimmer Biomet, as per their agreement. This development marks a significant milestone for the company and its efforts to expand its market presence.
In November 2022, EMOTIV Partnered with X-trodes to launched New Medical-Grade, At-Home Solution for Brain Monitoring Research. X-trodes' wearable sensing technology is partnered with EmotivPRO, a neuroscience data platform, to enhance sleep studies and kinesiology research. The proprietary dry-printed electrodes stream user-generated data through the EmotivPRO mobile app, allowing processing and analysis on the cloud-based platform.
In October 2022 Nihon Kohden launched a new product called the Smart Cable NMT Pod and disposable electrode. This device allows clinicians to objectively monitor the depth of paralysis in patients during surgery when a neuromuscular blockade agent (NMBA) is administered, whether non-depolarizing or depolarizing. With this innovation, clinicians can confidently monitor neuromuscular blockade, improving patient outcomes and enhancing surgical procedures.

Why Purchase the Report?

To visualize the global medical electrodes market segmentation based on product type, type, application, end user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of medical electrodes market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global medical electrodes report would provide approximately 53 tables, 54 figures and 195 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Type
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in the Prevalence of Cardiovascular Diseases
  - 4.1.1.2. Rise in Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Stringent Government Regulations
- 4.1.3. Opportunity
  - 4.1.3.1. Rising Focus toward Minimally Invasive Surgeries
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post Covid-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Diagnostic Medical Electrodes *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Therapeutic Medical Electrodes

8. By Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 8.1.2. Market Attractiveness Index, By Type
8.2. Wet Electrodes *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Dry Electrodes
8.4. Needle Electrodes

9. By Application

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Application
- 9.1.2. Market Attractiveness Index, By Product Application
9.2. Cardiology *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Neurophysiology
9.4. Sleep Disorders
9.5. Intraoperative Monitoring
9.6. Others

10. By End User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals *
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Diagnostic Centers
10.4. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. U.K.
  - 11.3.7.3. France
  - 11.3.7.4. Spain
  - 11.3.7.5. Italy
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. Medtronic *
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Koninklijke Philips N.V.
13.3. Ambu
13.4. Natus Medical Incorporated
13.5. 3M
13.6. CONMED Corporation
13.7. Rhythmlink International, LLC
13.8. Leonhard Lang GmbH
13.9. Nihon Kohden Corporation
13.10. Compumedics

LIST NOT EXHAUSTIVE